HK1204604A1 - Stereoselective total synthesis of noribogaine - Google Patents

Stereoselective total synthesis of noribogaine Download PDF

Info

Publication number
HK1204604A1
HK1204604A1 HK15103583.0A HK15103583A HK1204604A1 HK 1204604 A1 HK1204604 A1 HK 1204604A1 HK 15103583 A HK15103583 A HK 15103583A HK 1204604 A1 HK1204604 A1 HK 1204604A1
Authority
HK
Hong Kong
Prior art keywords
noribogaine
total synthesis
stereoselective total
stereoselective
synthesis
Prior art date
Application number
HK15103583.0A
Other languages
English (en)
Chinese (zh)
Inventor
Robert M. Moriarty
Deborah C. Mash
Original Assignee
Demerx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demerx, Inc. filed Critical Demerx, Inc.
Publication of HK1204604A1 publication Critical patent/HK1204604A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK15103583.0A 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine HK1204604A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161568568P 2011-12-08 2011-12-08
US201161568568P 2011-12-08
PCT/US2012/067629 WO2013085850A2 (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Publications (1)

Publication Number Publication Date
HK1204604A1 true HK1204604A1 (en) 2015-11-27

Family

ID=48575047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103583.0A HK1204604A1 (en) 2011-12-08 2012-12-03 Stereoselective total synthesis of noribogaine

Country Status (10)

Country Link
US (2) US8937061B2 (enExample)
EP (1) EP2788355A4 (enExample)
JP (1) JP2015509076A (enExample)
CN (1) CN104364256A (enExample)
CA (2) CA3122767C (enExample)
HK (1) HK1204604A1 (enExample)
IL (1) IL232724A (enExample)
IN (1) IN2014CN04160A (enExample)
WO (1) WO2013085850A2 (enExample)
ZA (1) ZA201403995B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
JP6049615B2 (ja) 2010-07-23 2016-12-21 デマークス・インコーポレイテッドDemerx,Inc. ノリボガイン組成物
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine
WO2013112757A1 (en) * 2012-01-25 2013-08-01 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
CA2942638C (en) 2013-03-15 2026-03-10 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
AU2014383143A1 (en) 2014-02-18 2016-09-29 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
US9345711B2 (en) 2014-02-18 2016-05-24 Demerx, Inc. Methods for acute and long-term treatment of drug addiction
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
WO2015195673A2 (en) 2014-06-18 2015-12-23 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
ES2867174T3 (es) 2014-11-26 2021-10-20 Demerx Inc Métodos y composiciones para potenciar la acción de analgésicos opioides mediante el uso de alcaloides de iboga
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
JP2022529781A (ja) 2019-04-17 2022-06-24 コンパス パスファインダー リミテッド サイロシビンによるうつ病及び他の様々な障害の治療
EP4587019A2 (en) 2022-09-14 2025-07-23 The Board of Trustees of the Leland Stanford Junior University Compositions of iboga alkaloids and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813873A (en) * 1957-11-19 Derivatives of the ibogaine alkaloids
US3639408A (en) * 1967-06-03 1972-02-01 Shionogi & Co Process for the preparation of isoquinuclidine derivatives
ES2264562T3 (es) 1994-07-25 2007-01-01 Nda International, Inc. Uso de derivados de noribogaina para tratar la dependencia quimica en mamiferos.
US5616575A (en) * 1995-12-04 1997-04-01 Regents Of The University Of Minnesota Bioactive tricyclic ibogaine analogs
US7220737B1 (en) * 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ES2435722T3 (es) * 1997-09-04 2013-12-23 Demerx, Inc. Noribogaína en el tratamiento del dolor y de la adicción a drogas
CN102225937B (zh) * 2011-05-04 2012-07-25 中国科学院昆明植物研究所 抗肿瘤生物碱类化合物,其药物组合物及其制备方法和应用
CA3122767C (en) 2011-12-08 2023-03-28 Demerx, Inc. Stereoselective total synthesis of noribogaine

Also Published As

Publication number Publication date
IL232724A (en) 2017-07-31
CN104364256A (zh) 2015-02-18
US9403837B2 (en) 2016-08-02
WO2013085850A3 (en) 2014-12-18
IN2014CN04160A (enExample) 2015-07-17
EP2788355A2 (en) 2014-10-15
JP2015509076A (ja) 2015-03-26
CA2856551C (en) 2021-06-22
CA3122767C (en) 2023-03-28
CA2856551A1 (en) 2013-06-13
WO2013085850A2 (en) 2013-06-13
US20130165647A1 (en) 2013-06-27
CA3122767A1 (en) 2013-06-13
IL232724A0 (en) 2014-08-03
EP2788355A4 (en) 2015-10-21
US8937061B2 (en) 2015-01-20
ZA201403995B (en) 2016-09-28
US20150005492A1 (en) 2015-01-01

Similar Documents

Publication Publication Date Title
IN2014CN04160A (enExample)
WO2012103028A3 (en) Methods and compositions for preparing noribogaine from voacangine
WO2012135047A3 (en) Methods and compositions for preparing noribogaine from voacangine
AP3450A (en) Process for the synthesis of methanol
IL221170A0 (en) Processes of synthesizing dihydropyridophthalazinone derivatives
EP2667714A1 (en) Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
IL223220A0 (en) Synthetic process for the manufacture of ecteinascidin compounds
IL226677A (en) Beta-amyloid production compounds
IL224954B (en) A production method of an intermediate compound for the synthesis of a drug
HK1199896A1 (en) Novel compositions for producing cast polyamides
WO2012174229A3 (en) Methods for the synthesis and purification of deoxycholic acid
IN2014DN09451A (enExample)
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
WO2013072938A3 (en) Process for the preparation of roflumilast
EP2679649A4 (en) Additive for increasing toughness of marble glue
WO2013030654A8 (en) Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof
WO2010008734A3 (en) Methods of Preparing Imidazole-Based Bicyclic Compounds
MX2014002630A (es) Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
PL2710014T3 (pl) Sposób syntezy rifaksyminy
HK1189583A (en) Method for synthesizing ketobenzofuran derivatives
HK1189582A (en) Process for synthesizing keto-benzofuran derivatives
HK1191937A (zh) 合成金属中卟啉的方法
HK1197236B (en) Compounds for the treatment of addiction
AU2011900738A0 (en) Novel Small-Molecules as Therapeutics